Story perspectives
Revolutionary Heart-On-A-Chip Enables Personalized Drug Testing
2/18/2026
1 of 1
Story summary
- Canadian researchers have developed a three-dimensional heart-on-a-chip that beats autonomously and responds predictably to drugs.
- The device enables real-time monitoring of both large-scale contractions and cellular activity.
- It integrates dual-sensing technology to assess how heart muscle cells react to norepinephrine and blebbistatin.
- Future work aims to create patient-specific heart tissues for personalized medication testing and precision health.
